Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan
· Delayed Price · Currency is JPY 4,436.00
+104.00 (2.40%)
May 2, 2025, 12:43 PM JST
TYO:4530 Revenue
In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B JPY with 10.09% growth. Hisamitsu Pharmaceutical Co. had revenue of 44.75B in the quarter ending February 28, 2025, with 15.11% growth.
Revenue
156.01B
Revenue Growth
+10.09%
P/S Ratio
2.03
Revenue / Employee
56.54M
Employees
2,759
Market Cap
317.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |